These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24543314)

  • 41. [VIOMYCIN IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    RENARD J; SIROT J; PUVINEL B; BERTRAND Y; ROY R
    Fr Med; 1964 Jan; 27():5-16. PubMed ID: 14135346
    [No Abstract]   [Full Text] [Related]  

  • 42. Agar diffusion methods for the assay of viomycin.
    EHRLICH J; IVERSON WP; KOHBERGER D
    Antibiot Chemother (Northfield); 1951 Jul; 1(4):211-6. PubMed ID: 24541117
    [No Abstract]   [Full Text] [Related]  

  • 43. [Viomycin, new antituberculosis drug].
    BARTOLOZZI G
    Riv Clin Pediatr; 1951 Mar; 49(3):121-31. PubMed ID: 14845536
    [No Abstract]   [Full Text] [Related]  

  • 44. [A new antibiotic against tuberculosis viomycin].
    PLICHET A
    Presse Med (1893); 1951 Feb; 59(11):219-20. PubMed ID: 14816326
    [No Abstract]   [Full Text] [Related]  

  • 45. [New antibiotic in tuberculosis therapy; viomycin].
    OLLERO DE LA ROSA E
    Hisp Med; 1951 Jan; 8(79):187-91. PubMed ID: 14813643
    [No Abstract]   [Full Text] [Related]  

  • 46. Bacteriological and pharmacological studies with viomycin.
    HEIN H
    Arzneimittelforschung; 1952 Nov; 2(11):521-3. PubMed ID: 13031947
    [No Abstract]   [Full Text] [Related]  

  • 47. [The intravenous administration of viomycin in the treatment of pulmonary tuberculosis].
    POZZETTO H
    Poumon Coeur; 1963; 19():445-58. PubMed ID: 13985868
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of synergism to increase the sensitivity of a microbiological method for the assay of viomycin.
    DYE WE; LYNCH HP; CULLEN TM; SPRAGUE EM
    Antibiot Chemother (Northfield); 1952 Dec; 2(12):610-4. PubMed ID: 24542151
    [No Abstract]   [Full Text] [Related]  

  • 49. [Physical, chemical and pharmacodynamic study of antibiotics. 10. Viomycin].
    Therapie; 1960; 15():763-80. PubMed ID: 14448000
    [No Abstract]   [Full Text] [Related]  

  • 50. [Derivatives of viomycin. 3. Viomycin-methyltetracyclines, their preparation and properties].
    Sobiczewski W; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1968; 25(6):563-7. PubMed ID: 4307876
    [No Abstract]   [Full Text] [Related]  

  • 51. [Viomycin and viomycin pantothenate with reduced toxicity in therapy of pulmonary tuberculosis].
    KUNTZ E
    Arzneimittelforschung; 1957 Apr; 7(4):233-7. PubMed ID: 13436325
    [No Abstract]   [Full Text] [Related]  

  • 52. [An antibiotic specifically active against mycobacteria: viomycin].
    CURCI G
    Prog Med (Napoli); 1951 Jul; 7(13):403-5. PubMed ID: 14864713
    [No Abstract]   [Full Text] [Related]  

  • 53. [A new tuberculosis antibiotic; viomycin].
    Resen Clin Cient; 1952 Oct; 21(10):350. PubMed ID: 13027645
    [No Abstract]   [Full Text] [Related]  

  • 54. [VIOMYCIN IN THE TREATMENT OF TUBERCULOSIS. INDICATIONS AND TOLERANCE].
    KALB JC; POZZETTO H; QUENEAU P
    Rev Tuberc Pneumol (Paris); 1964; 28():835-40. PubMed ID: 14236400
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical study of the tolerance of viomycin by the cochlear apparatus and the kidney].
    PERNOD J; ROBERT P; KERMAREC J
    Therapie; 1962; 17():1169-83. PubMed ID: 13942507
    [No Abstract]   [Full Text] [Related]  

  • 56. [Derivatives of viomycin. II. Preparation and properties of some viomycin penicillinates].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A; Cendrowska H
    Acta Pol Pharm; 1968; 25(4):407-10. PubMed ID: 4299476
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies of viomycin, an anti-tuberculosis antibiotic: copper(ii) coordination, DNA degradation and the impact on delta ribozyme cleavage activity.
    Stokowa-Sołtys K; Barbosa NA; Kasprowicz A; Wieczorek R; Gaggelli N; Gaggelli E; Valensin G; Wrzesiński J; Ciesiołka J; Kuliński T; Szczepanik W; Jeżowska-Bojczuk M
    Dalton Trans; 2016 May; 45(20):8645-58. PubMed ID: 27143296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [EXPERIENCE WITH THE THERAPEUTIC USE OF FLORIMYCIN (VIOMYCIN) IN TUBERCULOSIS].
    POLIAKOVA SG
    Antibiotiki; 1963 Oct; 8():920-5. PubMed ID: 14136422
    [No Abstract]   [Full Text] [Related]  

  • 59. [ISOLATION, CHEMICAL PURIFICATION AND PROPERTIES OF FLORIMYCIN (VIOMYCIN)].
    MAMIOFE SM; OPARYSHEVA EF; GREBENIK MD; NAGORNAIA TN; PREOBRAZHENSKAIA EV
    Antibiotiki; 1963 Oct; 8():895-900. PubMed ID: 14136416
    [No Abstract]   [Full Text] [Related]  

  • 60. [PRIMARY RESISTANCE OF TUBERCLE BACILLI TO VIOMYCIN, ETHIONAMIDE, AND CYCLOSERINE].
    KOWALCZYK H; RADECKI A; LUKIANSKI M
    Gruzlica (1926); 1965 Jan; 33():31-4. PubMed ID: 14331696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.